Home/Filings/4/0000899243-22-000135
4//SEC Filing

GIANAKAKOS ANASTASIOS 4

Accession 0000899243-22-000135

CIK 0001831283other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:20 PM ET

Size

7.8 KB

Accession

0000899243-22-000135

Insider Transaction Report

Form 4
Period: 2021-12-29
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2021-12-29$6.49/sh+36,548$237,19736,548 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-12-2936,548109,647 total
    Exercise: $6.49Exp: 2030-12-17Ordinary Shares (36,548 underlying)
Holdings
  • Ordinary Shares

    (indirect: By Trust)
    309,623
Footnotes (1)
  • [F1]25% of the shares underlying the option vested and became exercisable on the first anniversary of the commencement date, December 17, 2021; the remainder shall vest and become exercisable in 3 equal annual installments such that the option shall be fully vested on December 17, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Issuer

LianBio

CIK 0001831283

Entity typeother

Related Parties

1
  • filerCIK 0001413822

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:20 PM ET
Size
7.8 KB